国际生殖健康/计划生育 ›› 2018, Vol. 37 ›› Issue (1): 15-19.

• 论著 • 上一篇    下一篇

112例基础黄体生成激素<2 IU/L患者行降调节长方案体外受精结局分析

倪丹,刘雨生,吴莉,季静娟,童先宏   

  1. 230001  合肥,安徽医科大学附属省立医院生殖医学中心
  • 收稿日期:2017-10-26 修回日期:2018-01-08 出版日期:2018-01-15 发布日期:2018-02-02
  • 通讯作者: 刘雨生,E-mail:shengzhizhongxin@126.com E-mail:shengzhizhongxin@126.com
  • 基金资助:
    国家自然科学基金(81370757);安徽省自然科学基金(1608085MH202)

IVF Outcome of Long Down-Regulation Protocol in 112 Patients with Luteinizing Hormone <2 IU/L

NI Dan, LIU Yu-sheng, WU Li, JI Jing-juan, TONG Xian-hong   

  1. Reproductive Medicine center, Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, China
  • Received:2017-10-26 Revised:2018-01-08 Published:2018-01-15 Online:2018-02-02
  • Contact: LIU Yu-sheng, E-mail:shengzhizhongxin@126.com E-mail:shengzhizhongxin@126.com

摘要: 目的:了解基础黄体生成激素(LH)<2 IU/L患者行长方案体外受精/胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)的卵巢反应性及助孕结局,探讨其作为单项指标与卵巢储备功能的相关性。方法:选择2014年1月—2017年3月在安徽医科大学附属省立医院行IVF/ICSI-ET且基础卵泡刺激素(FSH)<10 IU/L的患者。根据患者年龄和LH水平分为4组,即A组:年龄≤35岁[25~35岁,平均年龄(28.86±3.10)岁],LH<2 IU/L,88例;B组:年龄≤35岁[25~35岁,平均年龄(28.48±3.72)岁],LH 2~5 IU/L,226例;C组:年龄>35岁[36~42岁,平均年龄(38.54±2.84)岁],LH<2 IU/L,24例;D组:年龄>35岁[36~42岁,平均年龄(37.64±2.40)岁],LH 2~5 IU/L,58例。对4组的超促排卵、胚胎数量和质量以及妊娠率相关数据进行比较。结果:A组基础日、降调日和促性腺激素(Gn)启动日LH水平低于B组,差异均有统计学意义(P<0.05);A组Gn总量较B组增加但差异无统计学意义(P>0.05);人绒毛膜促性腺激素(hCG)日E2水平、直径大于14 mm的卵泡数、获卵数、2原核(PN)胚胎数、优质胚胎数均低于B组,差异有统计学意义(P<0.05)。A组的FSH/LH均值为4.06。C组基础日、降调日和Gn启动日LH水平低于D组,差异均有统计学意义(P<0.05);C组Gn总量较D组增加但差异无统计学意义(P>0.05);C组hCG日E2水平、直径>14 mm的卵泡数、获卵数、2PN胚胎数、优质胚胎数与D组比较,差异无统计学意义(P>0.05)。C组的FSH/LH均值为4.23。A组与B组比较、C组与D组比较,hCG日LH水平、生化妊娠率和临床妊娠率差异均无统计学意义(P>0.05)。结论:年龄≤35岁且基础LH<2 IU/L,可以反映卵巢储备功能的状态并指导超排卵方案的选择。

关键词: 超排卵, 卵泡刺激素, 促黄体激素, 雌激素类, 受精, 体外, 胚胎移植

Abstract: Objective:To study the ovarian response and IVF/ICSI-ET outcome of the long GnRH-a protocol in those patients with base LH<2 IU/L, so as to explore the correlation of LH as a single index and ovarian reserve. Methods:Those patients undergoing IVF/ICSI-ET with the base FSH<10 IU/L from January 2014 to March 2017 were enrolled. According to the age and the base LH level, those patients were divided into four groups, the group A: age ≤35 years [25~35 years old, the average age (28.86±3.10)] and base LH<2 IU/L (n=88); the group B: age ≤35 years [25~35 years old, the average age (28.48±3.72)] and base LH 2~5 IU/L (n=226); the group C: age >35 years [36~42 years old, the average age (38.54±2.84)] and base LH<2 IU/L (n=24); the group D: age >35 years[36~42 years old, the average age (37.64±2.40)] and base LH 2~5 IU/L (n=58). The superovulation rate, the quantity and quality of embryo, and the pregnancy rate were compared. Results:The base LH level and LH levels on the down-regulated day and Gn starting day in the group A were significantly lower than those in the group B (P<0.05), while the total dose of Gn in the group A was higher than the group B (However, P>0.05). The E2 level on the day of hCG injection, the number of ≥14 mm follicles, the retrieved oocyte number, the number of 2PN and the number of high quality embryos in the group A were significantly lower than those in the group B (all P<0.05). The FSH/LH ratio in the group A was 4.06. The base LH level and LH levels on the down-regulated day and Gn starting day in the group C were significantly lower than those in the group D (P<0.05), while the total dose of Gn in the group C was higher (However, P>0.05). There were no significant differences in the E2 level on the day of hCG injection, the number of ≥14 mm follicles, the retrieved oocyte number, the number of 2PN and the number of high quality between the group A and group B (all P>0.05). The FSH/LH ratio in the group C was 4.23. Interestingly, there were no significantly differences in the LH level on the day of hCG injection, the rate of biochemical pregnancy and the rate of clinical pregnancy between the group A and group B, or between the group C and group D (both P>0.05). Conclusions:The age ≤35 and base LH<2 IU/L, as two parameters of ovarian reserve function, can be used as clinical references of ovarian stimulation protocols.
【Keywords】  

Key words: Superovulation, Follicle stimulating hormone, Luteinizing hormone, Estrogens, Fertilization in vitro, Embryo transfer